Evolving role of calcium channel blockers in heart failure

Pharmacotherapy

Volumn 16, Issue 2 II, 1996, Pages

  Pieper, John A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DILTIAZEM; DIURETIC AGENT; FELODIPINE; ISOSORBIDE DINITRATE; NICARDIPINE; NIFEDIPINE; NISOLDIPINE; NORADRENALIN; VERAPAMIL;

DRUG EFFICACY; DRUG SAFETY; EXERCISE TOLERANCE; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYMPATHETIC NERVE;

CALCIUM CHANNEL BLOCKERS; CARDIAC OUTPUT, LOW; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0029926861     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD) South Med J 1995,88:514-23.
2. Elkayam U, Shotan A, Mehra A, Ostrzega E. Calcium channel blockers in heart failure J Am Coll Cardiol 1993;22(suppl A).139A-44.
3. Magorien RD, Leier CV, Kolihash AJ, Barbush TJ, Unverferth DV. Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure. Circulation 1984;70:884-90.
4. Vlay SC, Olson L. Improvement in NYHA functional class IV congestive heart failure patients with nifedipine: a hemodynamic evaluation Am J Med Sci 1988;295 188-92
5. Elkayam U, Wever L, McKay CR, Rahimtoola SH. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. Am J Cardiol 1984;54:126-31.
6. Elkayam U, Wever L, Torkan B, McKay CR, Rahimotoola SH. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe congestive heart failure. Am J Cardiol 1984,53 1321-9.
7. Agnostoni PG, DeCesare N, Doria E, Polese A, Tamborini G, Guazzi M. Afterload reduction, a comparison of captopril and nifedipine in dilated cardiomyopathy. Br Heart J 1986;55 391-9
8. Elkayam U, Amin J, Mehra A, et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dmitrate and their combination in the treatment of chronic congestive heart failure Circulation 1990;82:1954-61
9. Packer M. Calcium channel blockers in chronic heart failure. the risks of "physiologically rational" therapy Circulation 1990,82 2254-7.
10. Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH. Inotropic vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. J Am Coll Cardiol 1985,5:1321-5
11. Elkayam U, Roth A, Hsueh W, Weber L, Freidenberger L, Rahimtoola SH. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure. Am Heart J 1986;111:1130-8.
12. The Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Eur Heart J 1984,5.516-28.
13. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990,66.779-85.
14. Kulick DL, McIntosh N, Campese VM, et al. Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. Circulation 1987;59:1138-43.
15. Packer M, Lee WH, Medina N, Yushak M. Comparative negative motropic effects of nifedipine and diltiazem in patients with severe left ventricular dysfunction [abstr] Circulation 1985,72(suppl 111) III-275.
16. Roth A, Harrison E, Mitani G, Cohen J, Rahimtoola SH, Elkayam U. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for heart rate control at rest and during exercise in patients with chronic atrial fibrillation. Circulation 1986,73:316-24.
17. Figulla HR, Rechenberg JV, Wiegand V, Soballa R, Kreuzer H. Beneficial effects of long-term treatment in dilated cardiomyopathy. J Am Coll Cardiol 1989;13:653-8.
18. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarcuon after myocardial infarction. N Engl J Med 1988;319 385-92.
19. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circluation 1991:83-52-60.
20. Gheorghiade M, Hall V, Goldberg D, Levine TB, Goldstein S. Long-term clinical and neurohormonal effects of nicardipine in patients with severe heart failure on maintenance therapy with angiotensin converting enzyme inhibitors [abstr]. J Am Coll Cardiol 1991;17(suppl A):274A.
21. Barjon JN, Rouleau JL, Bichet D, Juneau C, DeChamplain J. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol 1987;9:622-30.
22. Kassis E, Amtorp O. Long-term clinical, hemodynamic, angiographic and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol 1990;15:347-52.
23. Littler WA, Sheridan DJ, on behalf of the UK Study Group. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. Br Heart J 1995;75:428-33.
24. Cohn JN, Ziesche SM, Loss LE, et al. Effect of felodipine on short-term exercise and neurohormone and long-term mortality in heart failure: results of V-HeFT III [abstr]. Circulation 1995;92(suppl 1):I-143.
25. Packer M, Nicod P, Khandheria BR, et al. Randomized, multicenter. double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure [abstr] J Am Coll Cardiol 1991;17:274A.
26. O'Connor CM, Belkin RN, Carson PE, et al. Effect of amlodipine on mode of death in severe chronic heart failure: the PRAISE trial [abstr]. Circulation 1995;92(suppl 1) I-143.